Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00656487 · ClinicalTrials.gov registry record · Phase 2

Clinical and Neurobiological Effects of Cannabis Dependence in Young Adults

A Phase 2 study, sponsored by The Scripps Research Institute.

Completed
Registry status
Phase 2
Development phase
66
Enrollment target

NCT00656487 is a Phase 2 study that has completed, run by The Scripps Research Institute. The registered enrollment target is 66 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00656487, a Phase 2 study, has completed, sponsored by The Scripps Research Institute.

COMPLETED
Registry status
Phase 2
Development phase
66 participants
Enrollment target

Study Summary

The purpose of this study is to find out more about cognitive functioning in people who are cannabis dependent, relative to people who do not use cannabis, and how their brains process information after one month of not using cannabis. An additional goal is to characterize the severity of cannabis dependence using precipitated and naturalistic withdrawal with a double blind, placebo controlled, single administration of rimonabant. Research assessments occur bi-weekly throughout this 28 day study.

Interventions

  • DRUG placebo
  • DRUG rimonabant

Trial Details

FieldValue
Enrollment Target 66 participants
Start Date 2008-04-30
Est. Completion 2011-01-06
Phase Phase 2

Sponsor

The Scripps Research Institute

16 total trials

What the Registry Record Tells You About NCT00656487

The ClinicalTrials.gov registry entry for NCT00656487 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Scripps Research Institute, which has 16 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.

NCT00656487 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00656487 about?

NCT00656487 is a clinical study titled "Clinical and Neurobiological Effects of Cannabis Dependence in Young Adults". The purpose of this study is to find out more about cognitive functioning in people who are cannabis dependent, relative to people who do not use cannabis, and how their brains process information after one month of not using cannabis. An additional goal is to characterize the severity of cannabis d...

What is the current status of trial NCT00656487?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 66 participants. The study started on 2008-04-30. Estimated completion is 2011-01-06.

What interventions are being tested in trial NCT00656487?

The interventions under investigation include: placebo (DRUG), rimonabant (DRUG).

Who is sponsoring clinical trial NCT00656487?

This trial is sponsored by The Scripps Research Institute, which has 16 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.